AJR:197,August 2011
Jessica M. Davison, Rathan M. Subramaniam, Devaki S. Surasi, Timothy Cooley, Gustavo Mercier, Patrick J. Peller
OBJECTIVE. This article will discuss the 18F-FDG normal variant uptake and the role of FDG PET/CT in malignancies in HIV-infected patients, CNS manifestations of HIV, assessing fever of unknown origin in HIV patients, assessing response to highly active antiretroviral therapy and assessing complications.
CONCLUSION. FDG PET/CT is a valuable imaging study in the management of HIV-infected patients.